News
Biogen adding $2 billion to its RTP manufacturing campus
One of North Carolina’s largest life sciences companies, Biogen Inc. (Nasdaq BIIB), is celebrating its 30th anniversary in the state by announcing that it intends to invest an additional $2 billion at its two existing Research Triangle Park (RTP) campuses.
Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will increase.
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date ...
Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.
Since starting operations in North Carolina 30 years ago, Biogen has spent approximately $10 billion to bolster its ...
The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce ...
Quarterly Net Profit at Rs. 1.34 crore in June 2025 up 950.06% from Rs. 0.16 crore in June 2024. EBITDA stands at Rs. 1.34 ...
Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...
StockStory.org on MSN3d
Biogen (BIIB) Stock Trades Down, Here Is WhyShares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock ...
Modernization of “manufacturing technologies and controls through further advanced automation and artificial intelligence” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback